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A visual timeline tool for tracking mood and medication 
perinatally in affective disorders 
 
Amy Perry, K. Gordon-Smith, L. Jones & I. Jones  
Women with bipolar disorder are at particularly high risk of relapse following childbirth 
with almost one in five experiencing an episode of postpartum psychosis following 
delivery (Di Florio et al. 2013; Wesseloo et al. 2016). Factors which increase risk for 
severe postpartum relapse in women with bipolar disorder are poorly understood. 
The majority of previous research has traditionally employed retrospective methods of 
assessment, and/or has only measured a limited range of potential risk factors. High-
quality studies investigating risk factors prospectively in pregnant women with bipolar 
disorder are rare, and have predominantly focused on the role of medication use in 
postnatal relapse (Viguera et al. 2007).  
 
We are currently conducting a large-scale prospective pregnancy study to investigate 
factors which influence risk for severe postpartum mood episodes in women with 
bipolar disorder (UK Bipolar Disorder Research Network, www.BDRN.org). Women 
are recruited systematically through specialist perinatal psychiatry services 
nationwide, or non-systematically via national patient support charities. Lifetime and 
current psychopathology is assessed during pregnancy using a semi structured 
interview (Schedules for Clinical Assessment in Neuropsychiatry; Wing et al. 1990), 
and a follow-up SCAN interview is conducted at 12-week postpartum to assess 
psychopathology during the perinatal period. 
 
These data are combined with further information obtained at 12-week postpartum 
from clinician questionnaires and medical case records to determine both the 
occurrence of episodes of illness and medication use across the whole perinatal 
period. Data are also gathered on a wide range of potential risk and protective factors 
including obstetric complications, sleep loss, psychosocial factors relating to 
pregnancy (social support for example), comorbid physical and psychiatric conditions, 
menstrual history, and major adverse life events occurring lifetime ever and in the 
perinatal period specifically. These data are highly complex and multifaceted; there is 
considerable variation not only between participants but also individually throughout 
the perinatal period. For research, but also in clinical practice, there is a need to 
summarize this complex information and we have therefore developed a visual 
timeline tool as a means of graphically representing these detailed psychiatric and 
medication data longitudinally and simply across the perinatal period. Figure 1 
provides an example timeline generated from data collected during the second 
pregnancy of a participant with DSM-5 (American Psychiatric Association 2013) 
bipolar I disorder. This woman, who had a previous episode of postpartum psychosis, 
took quetiapine prophylactically throughout her pregnancy. She experienced an 
episode of major depression at 24 weeks gestation. Following an increase in the dose 
of quetiapine, she recovered and remained euthymic throughout the rest of the 
pregnancy. The quetiapine dose was increased again at 32 weeks of pregnancy and 
she delivered at 37 weeks. At 24 days postpartum, she developed an episode of 
postpartum psychosis requiring compulsory admission to a psychiatric mother and 
baby unit and the addition of further psychotropic medication. 
 
  
 
Fig. 1 A timeline representing course of illness and medication use during the perinatal 
period for a participant recruited to the Bipolar Disorder Research Network (BDRN) 
prospective pregnancy study. 
 
We have found this timeline tool to be a simple and efficient method of collating and 
presenting large amounts of complex clinical data for each perinatal period. Presenting 
these data graphically has allowed us to visually identify potential patterns in the data 
that are taken forward for formal testing. In addition to its use in research, we anticipate 
this tool would be equally useful in clinical practice for reviewing a patient’s perinatal 
psychiatric history. 
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